• Latest Posts

BMS steps into the European Market with its new Lung Cancer Treatment

NASDAQ-listed Biotech from Boston shops cancer-treating antibodies in Italy

Boehringer Ingelheim signs €661M deal for New Lung Cancer Treatment

NASDAQ-listed Sprint Bioscience sells early-stage Cancer Treatment to Bayer

Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi

AstraZeneca’s Oncology Expansion Continues: MedImmune grabs Inovio’s Cancer Vaccine


Roche and Clovis combine drugs to fight lung cancer, the most common cancer worldwide

Roche abandons Wilex to Make Way for Immuno-Oncology

Not only Genes matter, Cellular Origin determines the Cancer Type

New mAb-treatment Improves the Life of European Children with Neuroblastoma

Dutch Immuno-Oncology company raises Massive Series C Financing round

Leading German Biotechs MorphoSys and Immatics partner to pump up their Immuno-Oncology Therapies